I thought Pfizer-BioNTech was developed without government funding, although it was used to increase production.
I know BioNTech have said the development was never impeded by a lack of money. The technique was discovered by what turned into Curevac in Tübingen. The company was financed by Dietmar Hopp extremely rich founder of SAP, together with money from Bill Gates' Foundation, which no doubt will get conspiracy theorists going. Basically private enterprise has been at the back of it. Over the pandemic both German government and EU money has been made available.
It was Hopp incidentally who would not have allowed Trump to buy up Curevac and take the expertise to America on an 'America First' basis.
But, just under 18 million vaccinated out of what(?) 450 million people is hardly a stellar performance - whilst nearly 18 million have been vaccinated by no stretch of the imagination has Europe grasped the mettle as the UK have.
What von der Leyen got wrong was ordering too late and too little. To what extent that has held back the vaccination programme overall I don't know, but in theory it could be three months were lost. It really ought to be investigated, and her admission of mistakes was likewise too little and too late.
If comparisons have to be made, they should be between the EU and USA, as the difference there more accurately reflects the procurement policy. Trump deserves some credit for the US achievement.
What she cannot be blamed for is the enormous shortfall in the amounts promised but not delivered, both by Pfizer and AZ. The vaccine simply isn't yet being produced in sufficient quantities for a significant proportion of the EU population to be vaccinated.
There are countries from the poorer parts of the EU who are grateful for receiving any vaccine at all, they wouldn't have but for the joint approach to purchasing.
Also something that is in real danger of being forgotten is the situation in the developing countries. I was reading of an African country (I've forgotten which) with a population of millions which to date has receive
25 doses of vaccine. In all the interminable discussion programmes on this I have seen only a couple of people have brought this up. Desirable as it is to vaccinate the population of the richer West, there is a very real danger of others being left behind, and the virus and its mutations running riot across the African continent until the end of the year when the richer countries have done their populations.